Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Bibliografiset tiedot
Päätekijät: Macbeth, F, Griffiths, G, Noble, S, Burns, S, Maughan, T
Aineistotyyppi: Journal article
Julkaistu: 2009

Samankaltaisia teoksia